The contrast with biosimilar peptide GLP-1 agonists is significant
This could be due to genetic variations, nutrient deficiencies, toxins, infections, and/or the digestive issues often present in those with Hashimotos
Stomach acid is designed to break things down, but it can often destroy fragile nutrients like glutathione before they ever reach the small intestine for absorption
Your clinician will determine which peptide class, if any, is clinically appropriate based on your individual assessment, pathology results, and health goals
Glutathione may also mitigate free-radical damage linked to degenerative diseases, which may explain why its also been studied as a treatment for liver disease, Parkinsons, rheumatoid arthritis, and type 2 diabetes